Allogene Therapeutics, Inc.
ALLOFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Allogene Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 8 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 23, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| ProShare Advisors LLC | 2026-03-31 | 32,638 | $79.6K | SEC filing |
| Bell Investment Advisors, Inc | 2026-03-31 | 486 | $1.19K | SEC filing |
| Dynamic Technology Lab Private Ltd | 2026-03-31 | 18,122 | $44.2K | SEC filing |
| AMERIPRISE FINANCIAL INC | 2026-03-31 | 244,592 | $597K | SEC filing |
| CITIGROUP INC | 2026-03-31 | 353,335 | $862K | SEC filing |
| Aberdeen Group plc | 2026-03-31 | 1,462,219 | $3.57M | SEC filing |
| Focus Partners Wealth | 2026-03-31 | 19,256 | $47K | SEC filing |
| Coastal Bridge Advisors, LLC | 2026-03-31 | 21,789 | $53.2K | SEC filing |
| Creative Planning | 2026-03-31 | 364,809 | $890K | SEC filing |
| AXQ CAPITAL, LP | 2026-03-31 | 73,930 | $180K | SEC filing |
| HighTower Advisors, LLC | 2026-03-31 | 13,441 | $32.8K | SEC filing |
| Squarepoint Ops LLC | 2026-03-31 | 116,379 | $284K | SEC filing |
| True Wealth Design, LLC | 2026-03-31 | 809 | $1.97K | SEC filing |
| Mitsubishi UFJ Asset Management Co., Ltd. | 2026-03-31 | 428,700 | $1.05M | SEC filing |
| CHOREO, LLC | 2026-03-31 | 142,649 | $348K | SEC filing |
| LPL Financial LLC | 2026-03-31 | 172,250 | $420K | SEC filing |
| MAI Capital Management | 2026-03-31 | 2,107 | $5.14K | SEC filing |
| Arax Advisory Partners | 2026-03-31 | 834 | $2.04K | SEC filing |
| HSBC HOLDINGS PLC | 2026-03-31 | 260,404 | $638K | SEC filing |
| Twin Lakes Capital Management, LLC | 2026-03-31 | 740 | $1.81K | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Allogene Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-03-16 · Chang David D: Larger than 63 of the 64 other insider sales of Common Stock on file. SEC filing
- 2026-02-02 · Roberts Zachary: Larger than 58 of the 64 other insider sales of Common Stock on file. SEC filing
- 2026-02-02 · Chang David D: Larger than all 64 other insider sales of Common Stock on file. SEC filing
- 2025-10-21 · Parker Geoffrey M.: Larger than 59 of the 64 other insider sales of Common Stock on file. SEC filing
- 2025-06-10 · MESSEMER DEBORAH M.: Larger than 60 of the 64 other insider sales of Common Stock on file. SEC filing
- 2025-03-14 · Chang David D: Larger than 62 of the 64 other insider sales of Common Stock on file. SEC filing
- 2025-02-03 · Chang David D: Larger than 61 of the 64 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-04-21 | Yoshiyama Annie · SVP, Finance | Common Stock | S — Open market or private sale | −9,586 | 2.31 | SEC filing |
| 2026-03-31 | Beneski Benjamin Machinas · SVP, Chief Technical Officer | Common Stock | S — Open market or private sale | −2,867 | 2.50 | SEC filing |
| 2026-03-16 | Beneski Benjamin Machinas · SVP, Chief Technical Officer | Common Stock | S — Open market or private sale | −4,835 | 2.47 | SEC filing |
| 2026-03-16 | Chang David D · President and CEO | Common Stock | S — Open market or private sale | −47,763 | 2.47 | SEC filing |
| 2026-03-02 | Beneski Benjamin Machinas · SVP, Chief Technical Officer | Common Stock | S — Open market or private sale | −7,132 | 2.60 | SEC filing |
| 2026-02-02 | Parker Geoffrey M. · CHIEF FINANCIAL OFFICER | Common Stock | S — Open market or private sale | −24,001 | 1.76 | SEC filing |
| 2026-02-02 | Yoshiyama Annie · SVP, Finance | Common Stock | S — Open market or private sale | −4,167 | 1.72 | SEC filing |
| 2026-02-02 | Chang David D · President and CEO | Common Stock | S — Open market or private sale | −95,269 | 1.80 | SEC filing |
Showing 8 of 14 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-18 | Kazam Joshua A · Director | Common Stock | M — Exercise or conversion of derivative security | +47,700 | SEC filing |
| 2026-06-18 | Kazam Joshua A · Director | Restricted Stock Unit | M — Exercise or conversion of derivative security | −47,700 | SEC filing |
| 2026-06-18 | Barrett Elizabeth A. · Director | Restricted Stock Unit | A — Grant, award, or other acquisition | +95,400 | SEC filing |
| 2026-06-18 | Kazam Joshua A · Director | Restricted Stock Unit | A — Grant, award, or other acquisition | +95,400 | SEC filing |
| 2026-06-18 | SATO VICKI L · Director | Restricted Stock Unit | A — Grant, award, or other acquisition | +95,400 | SEC filing |
| 2026-06-18 | MESSEMER DEBORAH M. · Director | Restricted Stock Unit | A — Grant, award, or other acquisition | +95,400 | SEC filing |
| 2026-06-18 | WITTE OWEN N. · Director | Restricted Stock Unit | A — Grant, award, or other acquisition | +95,400 | SEC filing |
| 2026-06-18 | Humer Franz B · Director | Restricted Stock Unit | A — Grant, award, or other acquisition | +95,400 | SEC filing |
Showing 8 of 33 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2022-03-31 | PF Equity Holdings 2 B.V. · 10% owner | Common Stock | J — Other acquisition or disposition | −22,032,040 | SEC filing |
| 2022-03-14 (amended) | Belldegrun Arie · Director | Common Stock | J — Other acquisition or disposition | −4,710,120 | SEC filing |
| 2022-03-14 | Belldegrun Arie · Director | Common Stock | J — Other acquisition or disposition | −4,710,121 | SEC filing |
| 2022-03-14 | Belldegrun Arie · Director | Common Stock | J — Other acquisition or disposition | +4,710,121 | SEC filing |
| 2022-03-14 (amended) | Belldegrun Arie · Director | Common Stock | J — Other acquisition or disposition | +4,710,120 | SEC filing |
| 2022-03-07 | Kazam Joshua A · Director | Common Stock | J — Other acquisition or disposition | +412,618 | SEC filing |
Showing 6 of 6 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.